BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36812763)

  • 1. Aroylated phenylenediamine HO53 modulates innate immunity, histone acetylation and metabolism.
    Barrier ML; Myszor IT; Sahariah P; Sigurdsson S; Carmena-Bargueño M; Pérez-Sánchez H; Gudmundsson GH
    Mol Immunol; 2023 Mar; 155():153-164. PubMed ID: 36812763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Novel Inducer of Innate Immunity HO53 Stimulates Autophagy in Human Airway Epithelial Cells.
    Myszor IT; Sigurdsson S; Viktorsdottir AR; Agerberth B; Eskelinen EL; Ogmundsdottir MH; Gudmundsson GH
    J Innate Immun; 2022; 14(5):477-492. PubMed ID: 35078192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate Effector Systems in Primary Human Macrophages Sensitize Multidrug-Resistant Klebsiella pneumoniae to Antibiotics.
    Rekha RS; Karadottir H; Ahmed S; Gudmundsson GH; Agerberth B; Bergman P
    Infect Immun; 2020 Jul; 88(8):. PubMed ID: 32513857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel aroylated phenylenediamine compounds enhance antimicrobial defense and maintain airway epithelial barrier integrity.
    Myszor IT; Parveen Z; Ottosson H; Bergman P; Agerberth B; Strömberg R; Gudmundsson GH
    Sci Rep; 2019 May; 9(1):7114. PubMed ID: 31068616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDAC3 inhibitor RGFP966 controls bacterial growth and modulates macrophage signaling during Mycobacterium tuberculosis infection.
    Campo M; Heater S; Peterson GJ; Simmons JD; Skerrett SJ; Mayanja-Kizza H; Stein CM; Boom WH; Hawn TR
    Tuberculosis (Edinb); 2021 Mar; 127():102062. PubMed ID: 33639591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HDAC3 inhibitor RGFP966 ameliorated ischemic brain damage by downregulating the AIM2 inflammasome.
    Zhang MJ; Zhao QC; Xia MX; Chen J; Chen YT; Cao X; Liu Y; Yuan ZQ; Wang XY; Xu Y
    FASEB J; 2020 Jan; 34(1):648-662. PubMed ID: 31914678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effects of Pharmacological Inhibition of Histone Deacetylase 3 (HDAC3) in Huntington's Disease Mice.
    Jia H; Wang Y; Morris CD; Jacques V; Gottesfeld JM; Rusche JR; Thomas EA
    PLoS One; 2016; 11(3):e0152498. PubMed ID: 27031333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDAC 3-selective inhibitor RGFP966 demonstrates anti-inflammatory properties in RAW 264.7 macrophages and mouse precision-cut lung slices by attenuating NF-κB p65 transcriptional activity.
    Leus NG; van der Wouden PE; van den Bosch T; Hooghiemstra WTR; Ourailidou ME; Kistemaker LE; Bischoff R; Gosens R; Haisma HJ; Dekker FJ
    Biochem Pharmacol; 2016 May; 108():58-74. PubMed ID: 26993378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone acetylation in keratinocytes enables control of the expression of cathelicidin and CD14 by 1,25-dihydroxyvitamin D3.
    Schauber J; Oda Y; Büchau AS; Yun QC; Steinmeyer A; Zügel U; Bikle DD; Gallo RL
    J Invest Dermatol; 2008 Apr; 128(4):816-24. PubMed ID: 17943182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-specific expression of aquaporin-5 (Aqp5) in alveolar epithelium is directed by GATA6/Sp1 via histone acetylation.
    Flodby P; Li C; Liu Y; Wang H; Rieger ME; Minoo P; Crandall ED; Ann DK; Borok Z; Zhou B
    Sci Rep; 2017 Jun; 7(1):3473. PubMed ID: 28615712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of histone deacetylase 3 as a therapeutic target in castration-resistant prostate cancer.
    McLeod AB; Stice JP; Wardell SE; Alley HM; Chang CY; McDonnell DP
    Prostate; 2018 Mar; 78(4):266-277. PubMed ID: 29243324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of BRM/SMARCA2 sensitizes clear cell renal cell carcinoma to histone deacetylase complex inhibitors.
    Fang R; Pan R; Wang X; Liang Y; Wang X; Ma H; Zhou X; Xia Q; Rao Q
    Pathol Res Pract; 2020 Apr; 216(4):152867. PubMed ID: 32067803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting HDAC3 Activity with RGFP966 Protects Against Retinal Ganglion Cell Nuclear Atrophy and Apoptosis After Optic Nerve Injury.
    Schmitt HM; Schlamp CL; Nickells RW
    J Ocul Pharmacol Ther; 2018 Apr; 34(3):260-273. PubMed ID: 29211617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone Deacetylase Inhibition via RGFP966 Releases the Brakes on Sensory Cortical Plasticity and the Specificity of Memory Formation.
    Bieszczad KM; Bechay K; Rusche JR; Jacques V; Kudugunti S; Miao W; Weinberger NM; McGaugh JL; Wood MA
    J Neurosci; 2015 Sep; 35(38):13124-32. PubMed ID: 26400942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic therapy of cancer with histone deacetylase inhibitors.
    Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
    J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone Deacetylase 3 Inhibitor Alleviates Cerebellar Defects in Perinatal Hypothyroid Mice by Stimulating Histone Acetylation and Transcription at Thyroid Hormone-Responsive Gene Loci.
    Susetyo A; Ishii S; Fujiwara Y; Amano I; Koibuchi N
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of HDAC3 prevents diabetic cardiomyopathy in OVE26 mice via epigenetic regulation of DUSP5-ERK1/2 pathway.
    Xu Z; Tong Q; Zhang Z; Wang S; Zheng Y; Liu Q; Qian LB; Chen SY; Sun J; Cai L
    Clin Sci (Lond); 2017 Aug; 131(15):1841-1857. PubMed ID: 28533215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a histone deacetylase 3 inhibitor on extinction and reinstatement of cocaine self-administration in rats.
    Hitchcock LN; Raybuck JD; Wood MA; Lattal KM
    Psychopharmacology (Berl); 2019 Jan; 236(1):517-529. PubMed ID: 30488346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced histone H3 acetylation of the PD-L1 promoter via the COP1/c-Jun/HDAC3 axis is required for PD-L1 expression in drug-resistant cancer cells.
    Wang H; Fu C; Du J; Wang H; He R; Yin X; Li H; Li X; Wang H; Li K; Zheng L; Liu Z; Qiu Y
    J Exp Clin Cancer Res; 2020 Feb; 39(1):29. PubMed ID: 32024543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deacetylase-independent function of HDAC3 in transcription and metabolism requires nuclear receptor corepressor.
    Sun Z; Feng D; Fang B; Mullican SE; You SH; Lim HW; Everett LJ; Nabel CS; Li Y; Selvakumaran V; Won KJ; Lazar MA
    Mol Cell; 2013 Dec; 52(6):769-82. PubMed ID: 24268577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.